Immunotherapy with combined DNA vaccines is an effective treatment for M. bovis infection in cattle

Vaccine

Volumn 27, Issue 9, 2009, Pages 1317-1322

  Hu, Xi Dan ^a,b   Chen, Su Ting ^a   Yu, Da Hai ^a   Li, Shu Xia ^b   Cai, Hong ^a  

^a PEKING UNIVERSITY   (China)

^b Xinjiang Academy of Animal Science   (China)

Author keywords

Combined DNA vaccines; Immunotherapy; Mycobacterium bovis

Indexed keywords

BCG VACCINE; DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE TUBERCULOSIS; CALF (BOVINE); CATTLE DISEASE; CONTROLLED STUDY; IMMUNOTHERAPY; LUNG FIBROSIS; MALE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; CLONING, MOLECULAR; IMMUNOTHERAPY; LUNG; LUNG DISEASES; MYCOBACTERIUM BOVIS; TUBERCULIN TEST; TUBERCULOSIS, BOVINE; VACCINES, DNA;

EID: 59649108517     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.055     Document Type: Article

References (27)

1. Skinner M.A., Wedlock D.N., Buddle B.M., Hope J.C., and Villarreal-Ramos B. Vaccination of animals against Mycobacterium bovis. Rev Sci Technol 20 1 (2001) 112-132
2. Hope J.C., and Villarreal-Ramos B. Bovine TB and the development of new vaccines. Comp Immunol Microbiol Infect Dis 31 2-3 (2008) 77-100
3. Buddle B.M., Wards B.J., Aldwell F.E., Collins D.M., and de Lisle G.W. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20 7-8 (2002) 1126-1133
4. Reviriego Gordejo F.J., and Vermeersch J.P. Towards eradication of bovine tuberculosis in the European Union. Vet Microbiol 112 2-4 (2006) 101-109
5. Rosseels V., Marche S., Roupie V., Govaert M., Godfroid J., Walravens K., et al. Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle. Infect Immun 74 1 (2006) 202-212
6. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu Rev Immunol 19 (2001) 93-129
7. Munk M.E., and Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl 20 (1995) 668-675
8. Collins H.L., and Kaufmann S.H. The many faces of host responses to tuberculosis. Immunology 103 1 (2001) 1-9
9. Krieg A.M., Love-Homan L., Yi A.K., and Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 161 5 (1998) 2428-2434
10. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu Rev Immunol 15 (1997) 617-648
11. Lai W.C., Pakes S.P., Ren K., Lu Y.S., and Bennett M. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J Immunol 158 6 (1997) 2513-2516
12. Lowrie D.B., Tascon R.E., Bonato V.L., Lima V.M., Faccioli L.H., Stavropoulos E., et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 400 6741 (1999) 269-271
13. Silva C.L., Bonato V.L., Coelho-Castelo A.A., De Souza A.O., Santos S.A., Lima K.M., et al. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Ther 12 3 (2005) 281-287
14. Ha S.J., Jeon B.Y., Kim S.C., Kim D.J., Song M.K., Sung Y.C., et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Ther 10 18 (2003) 1592-1599
15. Ha S.J., Jeon B.Y., Youn J.I., Kim S.C., Cho S.N., and Sung Y.C. Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis. Gene Ther 12 7 (2005) 634-638
16. Zhu D., Jiang S., and Luo X. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection. Vaccine 23 37 (2005) 4619-4624
17. Liang Y., Wu X., Zhang J., Li N., Yu Q., Yang Y., et al. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Vaccine 26 35 (2008) 4536-4540
18. Yu D.H., Hu X.D., and Cai H. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83. Gene Ther 15 9 (2008) 652-659
19. Cai H., Tian X., Hu X.D., Li S.X., Yu D.H., and Zhu Y.X. Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection. Vaccine 23 30 (2005) 3887-3895
20. Altare F., Durandy A., Lammas D., Emile J.F., Lamhamedi S., Le Deist F., et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280 5368 (1998) 1432-1435
21. Orme I.M., Roberts A.D., Griffin J.P., and Abrams J.S. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 151 1 (1993) 518-525
22. Zhang M., Lin Y., Iyer D.V., Gong J., Abrams J.S., and Barnes P.F. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63 8 (1995) 3231-3234
23. Krieg A.M. Immune effects and mechanisms of action of CpG motifs. Vaccine 19 6 (2000) 618-622
24. Derrick S.C., Repique C., Snoy P., Yang A.L., and Morris S. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis. Infect Immun 72 3 (2004) 1685-1692
25. De Groot A.S., McMurry J., Marcon L., Franco J., Rivera D., Kutzler M., et al. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 23 17-18 (2005) 2121-2131
26. Welsh M.D., Kennedy H.E., Smyth A.J., Girvin R.M., Andersen P., and Pollock J.M. Responses of bovine WC1(+) gammadelta T cells to protein and nonprotein antigens of Mycobacterium bovis. Infect Immun 70 11 (2002) 6114-6120
27. Kennedy H.E., Welsh M.D., Bryson D.G., Cassidy J.P., Forster F.I., Howard C.J., et al. Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1(+) gamma delta T cells. Infect Immun 70 3 (2002) 1488-1500